New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 6, 2014
10:45 EDTPH, CIE, SDT, CRTO, WMGI, EGLE, WETF, FXC, CEQP, INFYHigh option volume stocks:
High option volume stocks: INFY CEQP FXC WETF EGLE WMGI CRTO SDT CIE PH
News For INFY;CEQP;FXC;WETF;EGLE;WMGI;CRTO;SDT;CIE;PH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
October 28, 2014
07:29 EDTWMGITornier downgraded to Market Perform from Outperform at William Blair
Subscribe for More Information
07:13 EDTWMGIWright Medical removed from Focus List at JPMorgan
Subscribe for More Information
06:38 EDTWMGIWright Medical downgraded to Buy from Strong Buy at Needham
Subscribe for More Information
06:24 EDTWMGIWright Medical upgraded to Outperform from Sector Perform at RBC Capital
05:32 EDTWMGITornier downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo downgraded Tornier (TRNX) to Market Perform citing the merger deal with Wright Medical (WMGI). Wells sees a low likelihood of another suitor emerging.
October 27, 2014
18:26 EDTWMGIOn The Fly: After Hours Movers
Subscribe for More Information
17:26 EDTEGLEStrategic Value Partners reports 5.74% passive stake in Eagle Bulk Shipping
Subscribe for More Information
16:46 EDTEGLEDavidson Kempner Partners reports 11.47% passive stake in Eagle Bulk Shipping
16:29 EDTWMGIWright Medical sees Tornier deal accretive to adjusted EBITDA in second year
Subscribe for More Information
16:29 EDTWMGIWright Medical to acquire Tornier in all-stock deal, own 52% of combined company
Subscribe for More Information
16:25 EDTWMGIWright Medical announces receipt of FDA approvable letter for Augment bone graft
Wright Medical Group announced that its BioMimetic subsidiary has received an Approvable Letter from the FDA for its Premarket Approval Application for Augment Bone Graft. The approvable letter indicates that FDA determined Augment Bone Graft to be safe and effective as an alternative to autograft for ankle and/or hindfoot fusion indications and is approvable subject to customary preapproval facilities inspections. Robert Palmisano, president and CEO of Wright Medical, stated, “Today’s positive news on the approvability of Augment Bone Graft is a major milestone that paves the way for commercialization in the U.S. and further underscores our strength in Biologics. Augment will provide clear benefits to patients and physicians and is expected to be a significant catalyst and meaningful new future growth driver for our business. We will work swiftly to address the inspection requirements set forth in the approvable letter and expect our U.S. foot and ankle commercial team to be ready to launch immediately upon final approval.” The company will work with the FDA to coordinate any preapproval inspections. Assuming satisfactory completion of this activity and receipt of a final approval order from the FDA, commercial sale and distribution of Augment Bone Graft can begin in the U.S.
16:19 EDTWMGIWright Medical, Tornier agree to merge in $3.3B transaction
Subscribe for More Information
15:36 EDTPHNotable companies reporting before tomorrow's open
Subscribe for More Information
October 23, 2014
11:19 EDTPHParker-Hannifin capital plans positive, timing uncertain, says Wells Fargo
Wells Fargo believes Parker-Hannifin's capital return plans are positive, but were a catalyst that investors have been "somewhat anticipating." The firm maintains its Market Perform rating and $113-$116 price target range on Parker-Hannifin despite the dividend raise and buyback, given the uncertainty regarding its planned pace of stock repurchases.
October 22, 2014
17:07 EDTPHParker-Hannifin authorizes repurchase of up to 35M shares
Subscribe for More Information
17:06 EDTPHParker-Hannifin raises quarterly dividend to 63c per share from 48c per share
Subscribe for More Information
12:19 EDTCIEOptions with decreasing implied volatility
Subscribe for More Information
October 21, 2014
10:00 EDTCIEOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: AbbVie (ABBV) downgraded to Neutral from Buy at Guggenheim... BHP Billiton (BHP) downgraded to Hold from Buy at Jefferies... Bank of Marin (BMRC) downgraded to Market Perform from Outperform at Keefe Bruyette... Cobalt (CIE) downgraded to Speculative Buy from Buy at Global Hunter... Consolidated Edison (ED) downgraded to Underweight at Morgan Stanley... Deutsche Post (DPSGY) downgraded to Hold from Buy at Deutsche Bank... HCP (HCP) downgraded to Hold from Buy at Jefferies... IBM (IBM) downgraded to Hold from Buy at Evercore... Inland Real Estate (IRC) downgraded to Underperform from Neutral at BofA/Merrill... PerkinElmer (PKI) downgraded to Neutral from Buy at Janney Capital... Philips (PHG) downgraded to Neutral at UBS... QEP Midstream Partners (QEPM) downgraded to Market Perform at Wells Fargo... Rent-A-Center (RCII) downgraded to Market Perform from Outperform at Raymond James... Rhino Resources (RNO) downgraded to Underperform from Market Perform at Raymond James... Universal Forest (UFPI) downgraded to Neutral from Buy at Sterne Agee.
08:29 EDTCIECobalt downgraded to Speculative Buy from Buy at Global Hunter
Subscribe for More Information
October 17, 2014
07:31 EDTWMGIWright Medical risk/reward positive into FDA decision, says JPMorgan
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use